McCormick, R., Blick, C., Ragoussis, J., Schoedel, J., Mole, D., Young, A., . . . Harris, A. (2013). miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis.
Chicago Style (17th ed.) CitationMcCormick, R., C. Blick, J. Ragoussis, J. Schoedel, D. Mole, A. Young, P. Selby, R. Banks, and A. Harris. MiR-210 Is a Target of Hypoxia-inducible Factors 1 and 2 in Renal Cancer, Regulates ISCU and Correlates with Good Prognosis. 2013.
MLA引文McCormick, R., et al. MiR-210 Is a Target of Hypoxia-inducible Factors 1 and 2 in Renal Cancer, Regulates ISCU and Correlates with Good Prognosis. 2013.
警告:這些引文格式不一定是100%准確.